Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
- Status
- RECRUITING
- Phase
- N/A
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
- Status
- RECRUITING
- Phase
- PHASE3
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
ELISA in Relapsed/Refractory MM
- Status
- RECRUITING
- Phase
- PHASE2
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Actual Use Trial of Tadalafil 5 mg
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Societal Burden Associated With Type 1 Diabetes in Canada
- Status
- RECRUITING
- Phase
- N/A
the Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY Disease
- Status
- RECRUITING
- Phase
- N/A
A Study to Assess Tolerability of the Trivalent Recombinant Vaccine in Individuals Aged 18 and Older Using the Vaccinees Perception of Injection Questionnaire
- Status
- COMPLETED
- Phase
- N/A
Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi Arabia
- Status
- COMPLETED
- Phase
- N/A